The top 20 Cardiology Business stories for February 2022
These were the most popular stories on Cardiology Business in February 2022:
1. Caffeine, energy drinks and other natural supplements can cause heart damage, cardiologists warn
2. Cardiac MRI sheds new light on COVID vaccine-related myocarditis
3. Heart drug trimetazidine at center of Olympics controversy surrounding figure skater Kamila Valieva
4. Late-breaking clinical trials announced for ACC.22
5. First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial
7. 4 new medications and technologies that could transform cardiology in 2022
10. Plant-based diets boost cardiovascular health, lower risk of severe COVID-19
11. Cardiologist dies after small plane crash in Minnesota
12. Additional lots of losartan recalled due to potential cancer risk
13. Implantable atrial shunt therapy trial identifies treatable HFpEF patients
15. Medtronic recalls a second directional atherectomy device due to risk of tip damage
16. HeartFlow calls off plans to merge, go public due to ‘unfavorable market conditions’
17. Recovered COVID-19 patients face higher risk of heart rate abnormalities, type 2 diabetes
18. Same-day discharge after LAAO is safe, cost-effective and ‘could become the new standard’
19. Abbott implantable heart failure monitor gains expanded FDA approval
20. Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment
Related top news stories content:
Most popular stories in Radiology Business from February 2022
The top 20 Health Executive stories for February 2022
Top Health Imaging stories in February 2022